3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Vitamin D Deficiency
2
Neoplasms
2
Myelodysplastic Syndromes
2
Renal Insufficiency, Chronic
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia
1
Hematologic Diseases
1
Cardiovascular Diseases
1
Bone Diseases, Metabolic
1
Anemia, Refractory, with Excess of Blasts
1
Anemia, Refractory
1
Anemia, Aplastic
1
Anemia
1
Interventions
Epoetin Alfa
55
Darbepoetin alfa
39
epoetin beta
14
ferric carboxymaltose
11
Lenalidomide
5
Cyclophosphamide
5
luspatercept
4
fludarabine phosphate
4
fludarabine
4
Erythropoietin
4
Cyclosporine
4
Cisplatin
4
Busulfan
4
Blood Transfusion
4
Biopsy
4
ACE-011
4
peginesatide
3
iron isomaltoside 1000
3
hematide
3
ferrous sulfate
3
ferric gluconate
3
Radiotherapy
3
Iron-Dextran Complex
3
Filgrastim
3
Ferric Oxide, Saccharated
3
Erythrocyte Transfusion
3
Antilymphocyte Serum
3
thymoglobulin
2
telapristone acetate
2
ruxolitinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anemia
×
Cholecalciferol
×
Classical hematology
×
Clear all
NCT01817699
2019-02-04
CANDLE-KIT
CANDLE-KIT Trial Study Group
Phase 4
Terminated
161 enrolled